https://ir.achievelifesciences.com/ https://ir.achievelifesciences.com/news-events https://ir.achievelifesciences.com/news-events/press-releases https://ir.achievelifesciences.com/news-events/ir-calendar https://ir.achievelifesciences.com/news-events/presentations https://ir.achievelifesciences.com/news-events/email-alerts https://ir.achievelifesciences.com/company-information https://ir.achievelifesciences.com/company-information/management-team https://ir.achievelifesciences.com/company-information/contacts https://ir.achievelifesciences.com/financial-information https://ir.achievelifesciences.com/financial-information/financial-results https://ir.achievelifesciences.com/stock-data/quote-chart https://ir.achievelifesciences.com/stock-data/historical-data https://ir.achievelifesciences.com/stock-data/analyst-coverage https://ir.achievelifesciences.com/sec-filings https://ir.achievelifesciences.com/sec-filings/all-sec-filings https://ir.achievelifesciences.com/sec-filings/annual-reports https://ir.achievelifesciences.com/sec-filings/quarterly-reports https://ir.achievelifesciences.com/sec-filings/section-16-filings https://ir.achievelifesciences.com/corporate-governance https://ir.achievelifesciences.com/corporate-governance/board-of-directors https://ir.achievelifesciences.com/corporate-governance/board-committees https://ir.achievelifesciences.com/corporate-governance/governance-documents https://ir.achievelifesciences.com/news-events/press-releases/detail/255/achieve-life-sciences-announces-publication-in-nicotine-tobacco-research-linking-cytisiniclines-receptor-selectivity-to-low-nausea-rates-and-favorable-tolerability 2026-03-26T08:30:03-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/254/achieve-life-sciences-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-business-updates 2026-03-24T07:00:06-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/253/achieve-life-sciences-to-announce-fourthquarterandfullyear2025-financial-results-and-host-conference-call-and-webcast-on-march-24-2026 2026-03-17T08:30:04-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/252/achieve-life-sciences-presents-data-at-srnt-demonstrating-successful-cessation-in-smokers-with-extensive-prior-treatment-exposure-and-on-participant-experience-in-the-orca-ol-study 2026-03-04T08:00:08-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/251/achieve-life-sciences-announced-granting-of-new-hire-inducement-awards 2026-01-30T16:05:01-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/250/achieve-life-sciences-confirms-promotion-of-dr-mark-rubinstein-to-chief-medical-officer 2026-01-12T08:47:00-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/249/achieve-life-sciences-to-host-meetings-during-the-j-p-morgan-healthcare-conference-week 2025-12-17T20:07:17-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/248/achieve-life-sciences-announced-granting-of-new-hire-inducement-awards 2025-12-08T16:10:54-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/247/achieve-life-sciences-reports-third-quarter-2025-financial-results-provides-updates-on-cytisinicline-program 2025-11-06T07:00:06-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/246/achieve-life-sciences-meets-key-milestones-advancing-cytisinicline-nda-for-smoking-cessation 2025-11-03T08:30:32-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/245/achieve-life-sciences-to-announce-third-quarter-financial-results-and-host-conference-call-and-webcast-on-november-6-2025 2025-10-29T08:30:10-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/244/achieve-life-sciences-appoints-erik-atkisson-as-chief-legal-officer 2025-10-20T08:30:12-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/243/achieve-life-sciences-receives-fda-commissioners-national-priority-voucher-for-cytisinicline-for-treatment-of-nicotine-dependence-for-e-cigarette-or-vaping-cessation 2025-10-17T07:30:02-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/242/achieve-life-sciences-announces-granting-of-new-hire-inducement-awards 2025-10-02T16:01:01-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/241/achieve-life-sciences-announces-publication-in-thorax-of-data-demonstrating-cytisiniclines-potential-efficacy-and-tolerability-for-smoking-cessation-in-individuals-with-copd 2025-09-22T08:30:04-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/240/achieve-life-sciences-promotes-craig-donnelly-to-chief-operations-officer 2025-09-18T08:30:02-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/239/achieve-life-sciences-names-dr-mark-rubinstein-interim-chief-medical-officer 2025-09-11T17:01:45-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/238/achieve-life-sciences-announces-fda-acceptance-of-cytisinicline-new-drug-application-for-treatment-of-nicotine-dependence-for-smoking-cessation 2025-09-03T08:30:08-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/237/achieve-life-sciences-announces-participation-at-upcoming-investor-conferences 2025-09-02T08:30:03-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/236/achieve-life-sciences-reports-second-quarter-2025-financial-results-provides-updates-on-cytisinicline-program 2025-08-07T07:30:10-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/235/achieve-life-sciences-to-participate-in-the-btig-virtual-biotechnology-conference 2025-07-29T08:30:05-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/234/achieve-life-sciences-to-announce-second-quarter-financial-results-and-host-conference-call-and-webcast-on-august-7-2025 2025-07-24T08:30:12-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/233/achieve-life-sciences-announces-closing-of-public-offering-of-common-stock-and-partial-exercise-of-underwriters-option-to-purchase-additional-securities 2025-06-30T19:52:41-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/232/achieve-life-sciences-announces-pricing-of-45-0-million-underwritten-public-offering 2025-06-26T23:43:34-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/230/achieve-life-sciences-announces-proposed-underwritten-public-offering 2025-06-26T16:08:29-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/231/achieve-life-sciences-announces-partnership-with-omnicom-to-execute-integrated-data-driven-launch-of-the-first-potential-new-treatment-for-nicotine-dependence-in-nearly-two-decades 2025-06-26T16:08:31-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/229/achieve-life-sciences-announces-submission-of-ndato-fda-for-cytisinicline-as-a-treatment-of-nicotine-dependence-for-smoking-cessation 2025-06-26T16:08:29-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/228/achieve-life-sciences-to-present-at-the-jefferies-global-healthcare-conference 2025-05-28T08:30:05-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/227/achieve-life-sciences-to-present-new-data-at-the-2025-ats-international-conference-demonstrating-that-cytisinicline-reduced-cravings-and-nicotine-intake 2025-05-20T08:30:07-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/226/achieve-life-sciences-reports-first-quarter-2025-financial-results-and-highlights-updates-in-cytisinicline-program 2025-05-13T07:30:07-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/225/achieve-life-sciences-to-announce-first-quarter-2025-financial-results-and-host-conference-call-and-webcast-on-may-13-2025 2025-05-06T08:30:03-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/224/achieve-life-sciences-announces-cytisinicline-phase-3-orca-3-trial-publication-on-smoking-cessation-in-jama-internal-medicine 2025-04-21T11:19:49-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/223/achieve-life-sciences-reports-financial-results-for-fourth-quarter-and-year-end-2024-and-provides-update-on-the-cytisinicline-development-program 2025-03-11T07:30:05-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/222/achieve-life-sciences-to-present-at-the-barclays-27th-annual-global-healthcare-conference 2025-03-07T08:30:01-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/221/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2024-financial-results-and-host-conference-call-and-webcast-on-march-11-2025 2025-03-06T08:30:06-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/220/achieve-life-sciences-to-present-at-the-oppenheimer-healthcare-life-sciences-conference 2025-02-11T08:30:10-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/219/achieve-life-sciences-announces-positive-outcome-of-second-data-safety-monitoring-committee-review-for-the-orca-ol-clinical-trial 2025-02-10T08:30:01-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/218/achieve-life-sciences-appoints-dr-kristen-slaoui-and-nancy-phelan-to-its-board-of-directors 2025-01-10T08:30:02-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/217/achieve-life-sciences-announces-critical-milestone-successfully-reached-in-orca-ol-cytisinicline-clinical-trial-required-for-nda-submission 2025-01-07T08:30:01-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/216/achieve-life-sciences-to-host-meetings-during-the-j-p-morgan-healthcare-conference-week 2025-01-06T08:30:02-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/215/achieve-life-sciences-appoints-mark-oki-as-chief-financial-officer 2024-12-09T08:30:02-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/214/achieve-life-sciences-to-advance-first-vaping-cessation-therapy-after-successful-end-of-phase-2-meeting-with-fda 2024-12-03T08:30:02-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/213/achieve-life-sciences-announces-participation-at-upcoming-investor-conferences 2024-11-14T08:30:02-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/212/achieve-life-sciences-reports-financial-results-for-third-quarter-2024-and-provides-corporate-update 2024-11-07T16:06:20-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/211/achieve-life-sciences-to-announce-third-quarter-financial-results-and-host-conference-call-and-webcast-on-november-7-2024 2024-10-24T08:00:07-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/210/achieve-life-sciences-president-and-cmo-dr-cindy-jacobs-speaks-at-fda-and-nih-smoking-cessation-public-meeting 2024-10-23T08:00:09-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/209/achieve-life-sciences-promotes-jaime-xinos-to-chief-commercial-officer-to-advance-commercial-readiness-of-cytisinicline 2024-10-16T08:00:17-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/208/achieve-life-sciences-announces-completion-of-enrollment-in-orca-ol-clinical-trial-successful-outcome-of-the-first-data-safety-monitoring-committee-meeting 2024-10-10T08:00:14-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/207/achieve-life-sciences-strengthens-leadership-with-appointment-of-dr-mark-rubinstein-nicotine-dependence-expert-as-new-head-of-medical-affairs 2024-10-01T08:45:38-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/206/achieve-life-sciences-announces-changes-in-executive-leadership-and-board-of-directors 2024-08-26T16:30:02-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/205/achieve-life-sciences-reports-financial-results-for-second-quarter-2024-and-provides-corporate-update 2024-08-13T16:01:01-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/204/achieve-life-sciences-announces-fda-grants-breakthrough-therapy-designation-to-cytisinicline-for-the-treatment-of-e-cigarette-or-vaping-nicotine-dependence 2024-07-31T08:00:09-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/203/achieve-life-sciences-announces-20m-loan-refinancing-with-silicon-valley-bank 2024-07-29T08:00:02-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/202/achieve-life-sciences-to-announce-second-quarter-financial-results-and-host-conference-call-and-webcast-on-august-13-2024 2024-07-25T08:00:01-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/201/achieve-life-sciences-to-present-at-joneshealthcare-seaside-summit-2024 2024-07-09T08:00:03-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/200/achieve-life-sciences-announces-addition-to-the-u-s-russell-3000-and-russell-microcap-indexes 2024-07-01T08:00:04-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/199/achieve-life-sciences-announces-initiation-of-orca-ol-clinical-trial-evaluating-long-term-exposure-of-cytisinicline-in-people-who-smoke-or-use-nicotine-e-cigarettes 2024-05-29T08:00:06-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/198/achieve-life-sciences-announces-data-from-cytisinicline-orca-v1-program-to-be-presented-at-society-of-general-internal-medicine-sgim-annual-meeting 2024-05-17T08:00:30-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/197/achieve-life-sciences-reports-financial-results-for-first-quarter-2024-and-provides-corporate-update 2024-05-09T16:01:29-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/196/achieve-life-sciences-announces-publication-of-cytisinicline-vaping-cessation-trial-results-in-jama-internal-medicine 2024-05-06T11:16:05-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/195/achieve-life-sciences-to-announce-first-quarter-financial-results-and-host-conference-call-and-webcast-on-may-9-2024 2024-04-25T08:00:07-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/194/achieve-life-sciences-to-present-at-life-science-innovation-northwest-2024-conference 2024-04-11T08:00:07-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/193/achieve-life-sciences-reports-financial-results-for-fourth-quarter-and-year-end-2023-and-provides-corporate-update 2024-03-28T16:01:23-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/192/achieve-life-sciences-announces-data-from-cytisinicline-orca-program-to-be-presented-at-the-2024-society-for-research-on-nicotine-and-tobacco-srnt-annual-meeting 2024-03-20T08:00:05-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/191/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2023-financial-results-and-host-conference-call-and-webcast-on-march-28-2024 2024-03-14T08:00:06-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/190/achieve-life-sciences-announces-participation-at-upcoming-investor-conferences 2024-03-06T08:00:02-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/189/achieve-life-sciences-reaches-agreement-with-the-fda-on-long-term-cytisinicline-exposure-data-requirements-for-nda-submission 2024-02-29T08:01:01-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/188/achieve-life-sciences-announces-pricing-of-up-to-124-2-million-registered-direct-offering-and-concurrent-private-placement 2024-02-29T08:00:06-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/187/achieve-life-sciences-announces-participation-at-upcoming-investor-conferences 2023-12-11T16:30:02-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/186/achieve-life-sciences-reports-financial-results-for-third-quarter-and-provides-corporate-update 2023-11-09T16:00:08-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/185/achieve-life-sciences-to-announce-third-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-november-9-2023 2023-10-26T08:00:02-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/184/achieve-life-sciences-announces-participation-at-upcoming-investor-conferences 2023-10-03T08:00:04-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/183/achieve-life-sciences-announces-presentation-of-cytisinicline-e-cigarette-cessation-orca-v1-results-at-society-for-research-on-nicotine-and-tobacco-europe-srnt-e-annual-meeting 2023-09-11T08:00:09-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/182/achieve-life-sciences-announces-participation-at-upcoming-investor-conferences 2023-09-07T08:00:08-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/181/achieve-life-sciences-reports-financial-results-for-second-quarter-2023-and-provides-corporate-update 2023-08-14T16:00:01-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/180/achieve-life-sciences-to-announce-second-quarter-2023-financial-results-and-host-conference-call-and-webcast 2023-08-01T08:00:07-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/179/achieve-life-sciences-announces-presentation-at-2023-american-society-of-pharmacognosy-annual-meeting 2023-07-18T08:00:02-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/178/achieve-life-sciences-announces-publication-of-cytisinicline-phase-3-orca-2-smoking-cessation-trial-in-journal-of-the-american-medical-association-jama 2023-07-11T11:23:27-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/177/achieve-life-sciences-announces-participation-at-upcoming-investor-conferences 2023-06-06T08:00:08-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/176/achieve-life-sciences-announces-pricing-of-16-5-million-registered-direct-offering 2023-05-25T09:00:05-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/175/achieve-life-sciences-reports-statistically-significant-smoking-cessation-benefit-for-cytisinicline-in-second-confirmatory-phase-3-clinical-trial 2023-05-23T06:00:02-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/174/achieve-life-sciences-announces-refinancing-of-outstanding-loan-with-silicon-valley-bank 2023-05-17T08:00:06-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/173/achieve-life-sciences-reports-financial-results-for-first-quarter-2023-and-provides-corporate-update 2023-05-09T16:05:17-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/172/achieve-life-sciences-to-announce-first-quarter-2023-financial-results-and-host-conference-call-and-webcast-on-may-9-2023 2023-04-26T08:00:05-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/171/achieve-life-sciences-announces-positive-phase-2-orca-v1-trial-results-showing-statistically-significant-vaping-cessation-benefit-for-participants-treated-with-cytisinicline 2023-04-20T08:00:10-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/170/achieve-life-sciences-to-present-at-life-science-innovation-northwest-2023-conference 2023-04-14T08:00:02-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/169/achieve-life-sciences-announces-refresh-to-board-of-directors 2023-03-30T08:00:04-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/168/achieve-life-sciences-announces-last-subject-last-visit-completed-in-phase-3-orca-3-trial-of-cytisinicline-for-smoking-cessation 2023-03-29T08:00:08-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/167/achieve-life-sciences-announces-granting-of-new-hire-inducement-award 2023-03-17T08:00:02-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/166/achieve-life-sciences-reports-financial-results-for-fourth-quarter-and-year-end-2022-and-provides-corporate-update 2023-03-16T16:05:08-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/165/achieve-life-sciences-reports-financial-results-for-fourth-quarter-and-year-end-2022-and-provides-corporate-update 2023-03-16T16:05:06-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/164/achieve-life-sciences-announces-last-subject-last-visit-completed-in-phase-2-orca-v1-trial-of-cytisinicline-for-e-cigarette-cessation 2023-03-08T08:00:06-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/163/achieve-life-sciences-announces-presentation-of-the-phase-3-orca-2-trial-of-cytisinicline-at-society-for-research-on-nicotine-and-tobacco-srnt-annual-meeting 2023-03-03T08:00:02-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/162/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2022-financial-results-and-host-conference-call-and-webcast-on-march-16-2023 2023-03-02T08:00:10-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/161/achieve-life-sciences-announces-last-subject-dosed-in-phase-2-orca-v1-trial-of-cytisinicline-for-e-cigarette-cessation 2023-02-07T08:00:12-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/160/achieve-life-sciences-to-participate-at-the-2023-svb-securities-global-biopharma-conference 2023-02-02T08:00:12-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/159/achieve-life-sciences-announces-granting-of-new-hire-inducement-award 2023-01-27T16:30:02-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/158/achieve-life-sciences-announces-last-subject-dosed-in-phase-3-orca-3-trial-of-cytisinicline-for-smoking-cessation 2023-01-09T08:00:11-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/157/achieve-life-sciences-announces-patent-granted-by-uspto-for-new-cytisinicline-formulation 2022-12-21T08:00:04-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/156/achieve-life-sciences-announces-private-placement-of-18-9-million 2022-11-15T08:00:12-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/155/achieve-reports-financial-results-for-third-quarter-2022-andprovides-corporate-update 2022-11-14T16:05:14-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/154/achieve-announces-early-completion-of-target-enrollment-in-cytisinicline-e-cigarette-cessation-trial 2022-11-08T08:00:08-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/153/achieve-life-sciences-to-announce-third-quarter-financial-results-and-host-conference-call-and-webcast-on-november-14-2022 2022-10-31T08:00:07-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/152/achieve-announces-completion-of-target-enrollment-in-the-phase-3-orca-3-trial-of-cytisinicline-for-smoking-cessation 2022-09-27T08:00:09-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/151/achieve-life-sciences-announces-participation-at-fall-investor-conferences 2022-09-07T08:00:18-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/150/achieve-reports-financial-results-for-second-quarter-2022-and-provides-corporate-update 2022-08-11T16:05:20-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/149/achieve-life-sciences-to-announce-second-quarter-financial-results-and-host-conference-call-and-webcast-on-august-11-2022 2022-07-28T08:00:06-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/148/achieve-life-sciences-announces-granting-of-new-hire-inducement-awards 2022-07-01T16:05:02-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/147/achieve-life-sciences-announces-initiation-of-phase-2-orca-v1-clinical-trial-evaluating-cytisinicline-for-nicotine-e-cigarette-cessation 2022-06-29T08:00:08-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/146/achieve-life-sciences-announces-participation-at-h-c-wainwright-1st-annual-mental-health-conference 2022-06-21T08:00:12-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/145/achieve-life-sciences-awarded-grant-from-the-national-institutes-of-health-to-conduct-phase-2-trial-of-cytisinicline-in-nicotine-e-cigarette-users 2022-06-01T08:00:24-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/144/achieve-life-sciences-announces-participation-at-ld-micro-invitational-conference 2022-05-26T08:00:05-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/143/achieve-life-sciences-announces-participation-at-best-ideas-virtual-investor-conference 2022-05-13T08:00:04-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/142/achieve-reports-financial-results-for-first-quarter-2022-and-provides-corporate-update 2022-05-12T16:00:03-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/141/achieve-life-sciences-announces-successful-statistically-significant-smoking-cessation-results-in-phase-3-orca-2-clinical-trial-of-cytisinicline-in-adult-smokers 2022-04-27T08:00:12-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/140/achieve-life-sciences-to-announce-first-quarter-financial-results-and-host-conference-call-and-webcast-on-may-12-2022 2022-04-21T08:00:13-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/139/achieve-life-sciences-announces-cytisinicline-presentation-at-society-for-research-on-nicotine-and-tobacco-srnt-annual-meeting 2022-03-15T08:00:09-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/138/achieve-life-sciences-announces-appointment-of-dr-vaughn-himes-to-board-of-directors 2022-03-14T08:00:00-04:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/137/achieve-life-sciences-announces-expansion-of-manufacturing-quality-operations-team-and-granting-of-inducement-award 2022-03-11T08:00:01-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/136/achieve-life-sciences-reports-financial-results-for-fourth-quarter-and-year-end-2021-and-provides-corporate-update 2022-03-10T08:00:06-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/135/achieve-life-sciences-announces-participation-in-march-investor-conferences 2022-03-08T08:00:02-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/5/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2021-financial-results-and-host-conference-call-and-webcast-on-march-10-2022 2022-02-28T11:36:59-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/6/achieve-life-sciences-announces-expansion-of-cytisinicline-clinical-operations-team-and-granting-of-inducement-award 2022-02-28T11:36:59-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/7/achieve-life-sciences-announces-participation-in-february-investor-conferences 2022-02-28T11:36:59-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/8/achieve-life-sciences-announces-initiation-of-the-phase-3-orca-3-clinical-trial-evaluating-cytisinicline-for-smoking-cessation 2022-02-28T11:37:00-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/9/achieve-life-sciences-to-present-at-h-c-wainwright-bioconnect-virtual-conference 2022-02-28T11:37:00-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/10/achieve-life-sciences-announces-completion-of-last-subject-last-follow-up-visit-in-phase-3-orca-2-trial-of-cytisinicline-for-smoking-cessation 2022-02-28T11:37:00-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/11/achieve-life-sciences-announces-25-million-loan-facility-from-silicon-valley-bank-to-fund-cytisinicline-smoking-cessation-clinical-development 2022-02-28T11:37:00-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/12/achieve-life-sciences-to-host-key-opinion-leader-panel-on-smoking-and-e-cigarette-cessation 2022-02-28T11:37:01-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/13/achieve-life-sciences-announces-phase-3-orca-2-trial-of-cytisinicline-in-smoking-cessation-clears-final-review-by-data-safety-monitoring-committee-dsmc 2022-02-28T11:37:01-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/14/achieve-reports-financial-results-for-third-quarter-2021-and-provides-update-on-cytisinicline-development 2022-02-28T11:37:01-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/15/achieve-life-sciences-announces-participation-in-november-investor-conferences 2022-02-28T11:37:01-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/16/achieve-life-sciences-announces-fda-acceptance-of-ind-application-for-cytisiniclines-second-planned-indication-for-nicotine-e-cigarette-cessation 2022-02-28T11:37:01-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/17/achieve-life-sciences-to-announce-third-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-november-9-2021 2022-02-28T11:37:02-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/18/achieve-life-sciences-to-participate-in-upcoming-investor-conferences 2022-02-28T11:37:02-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/19/achieve-life-sciences-announces-presentation-of-cytisinicline-data-at-the-21st-annual-society-for-research-on-nicotine-tobacco-srnt-e-virtual-conference 2022-02-28T11:37:02-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/20/achieve-life-sciences-to-participate-in-two-upcoming-investor-conferences 2022-02-28T11:37:02-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/21/achieve-life-sciences-announces-expansion-of-cytisinicline-clinical-operations-team-and-granting-of-inducement-awards 2022-02-28T11:37:02-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/22/achieve-reports-financial-results-for-second-quarter-2021-and-provides-corporate-update 2022-02-28T11:37:02-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/23/achieve-announces-two-patents-granted-by-uspto-for-novel-cytisinicline-dosing-and-administration-regimen 2022-02-28T11:37:03-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/24/achieve-life-sciences-to-announce-second-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-august-12-2021 2022-02-28T11:37:03-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/25/achieve-life-sciences-awarded-grant-from-the-national-institutes-of-health-nih-for-the-evaluation-of-cytisinicline-in-cessation-of-nicotine-e-cigarette-use 2022-02-28T11:37:03-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/26/achieve-announces-completion-of-target-enrollment-of-750-subjects-in-phase-3-orca-2-smoking-cessation-trial-of-cytisinicline 2022-02-28T11:37:03-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/27/achieve-announces-allowance-of-u-s-patents-for-dosing-and-administration-of-cytisinicline-for-the-treatment-and-prevention-of-addiction 2022-02-28T11:37:03-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/28/achieve-life-sciences-to-present-at-ld-micro-invitational-xi-virtual-conference 2022-02-28T11:37:03-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/29/achieve-life-sciences-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of-underwriters-option-to-purchase-additional-shares 2022-02-28T11:37:03-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/30/achieve-life-sciences-announces-pricing-of-20-million-underwritten-public-offering 2022-02-28T11:37:03-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/31/achieve-life-sciences-announces-proposed-underwritten-public-offering 2022-02-28T11:37:03-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/32/achieve-reports-financial-results-for-first-quarter-2021-and-provides-corporate-update 2022-02-28T11:37:04-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/33/achieve-life-sciences-to-announce-first-quarter-2021-financial-results-and-host-conference-call-and-webcast-on-may-13-2021 2022-02-28T11:37:04-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/34/achieve-life-sciences-inc-to-host-virtual-non-deal-roadshow-on-tuesday-april-27-2021 2022-02-28T11:37:04-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/35/achieve-announces-publication-of-the-orca-1-phase-2b-clinical-trial-of-cytisinicline-in-adult-smokers-in-nicotine-and-tobacco-research 2022-02-28T11:37:04-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/36/achieve-announces-publication-of-the-rauora-head-to-head-non-inferiority-clinical-trial-comparing-cytisinicline-and-chantixr-varenicline-in-addiction 2022-02-28T11:37:04-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/37/achieve-life-sciences-to-participate-in-m-vest-and-maxim-group-inaugural-emerging-growth-virtual-conference 2022-02-28T11:37:04-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/38/achieve-life-sciences-announces-appointment-of-dr-bridget-martell-and-dr-cindy-jacobs-to-board-of-directors 2022-02-28T11:37:04-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/39/achieve-reports-financial-results-for-fourth-quarter-and-year-end-2020-and-provides-corporate-update 2022-02-28T11:37:05-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/40/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2020-financial-results-and-host-conference-call-and-webcast-on-march-11-2021 2022-02-28T11:37:05-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/41/achieve-life-sciences-announces-presentation-of-data-on-smoker-and-e-cigarette-user-attitudes-and-perceptions-on-quitting-at-the-society-for-research-on-nicotine-tobacco-srnt-annual-meeting 2022-02-28T11:37:05-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/42/achieve-life-sciences-to-present-at-the-microcap-rodeo-winter-wonderland-conference-on-february-16-2021 2022-02-28T11:37:05-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/43/achieve-life-sciences-to-present-at-h-c-wainwright-virtual-bioconnect-conference 2022-02-28T11:37:05-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/44/achieve-life-sciences-inc-announces-closing-of-17-3-million-underwritten-public-offering-including-full-exercise-of-overallotment-option 2022-02-28T11:37:05-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/45/achieve-life-sciences-announces-pricing-of-15-million-public-offering 2022-02-28T11:37:06-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/46/achieve-life-sciences-announces-proposed-public-offering 2022-02-28T11:37:06-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/47/achieve-reports-financial-results-for-third-quarter-2020-and-provides-corporate-and-cytisinicline-development-update 2022-02-28T11:37:06-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/48/achieve-life-sciences-to-announce-third-quarter-2020-financial-results-and-host-conference-call-and-webcast-on-november-12-2020 2022-02-28T11:37:07-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/49/achieve-life-sciences-to-host-smoking-cessation-key-opinion-leader-virtual-roundtable-on-november-17th-2020 2022-02-28T11:37:07-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/50/achieve-life-sciences-announces-to-present-at-the-microcap-best-ideas-conference-october-13-2020 2022-02-28T11:37:07-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/51/achieve-life-sciences-announces-start-of-phase-3-orca-2-clinical-trial-evaluating-cytisinicline-for-smoking-cessation 2022-02-28T11:37:07-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/52/achieve-life-sciences-announces-appointment-of-john-bencich-to-chief-executive-officer-dr-cindy-jacobs-to-president 2022-02-28T11:37:07-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/53/achieve-announces-presentation-of-investigator-led-rauora-trial-data-demonstrating-significantly-fewer-side-effects-with-higher-quit-rates-for-cytisinicline-cytisine-compared-to-chantix-varenicline-in-first-head-to-head-comparative-study 2022-02-28T11:37:07-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/54/achieve-life-sciences-announces-results-from-evaluation-of-cytisinicline-cytisine-versus-chantix-varenicline-in-5-ht3-receptor-binding-assay-study 2022-02-28T11:37:08-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/55/achieve-life-sciences-announces-presentation-of-cytisinicline-data-at-the-20th-annual-society-for-research-on-nicotine-tobacco-europe-srnt-e-virtual-conference 2022-02-28T11:37:08-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/56/achieve-life-sciences-to-present-at-upcoming-investor-conferences 2022-02-28T11:37:08-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/57/achieve-reports-financial-results-for-second-quarter-2020-and-provides-update-on-cytisinicline-development-program 2022-02-28T11:37:08-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/58/achieve-life-sciences-announces-pricing-of-6-5-million-public-offering 2022-02-28T11:37:08-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/59/achieve-life-sciences-announces-proposed-public-offering 2022-02-28T11:37:08-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/60/achieve-announces-patent-granted-in-the-u-s-for-novel-analogs-of-cytisinicline-for-use-in-cns-and-addiction-indications 2022-02-28T11:37:09-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/61/achieve-life-sciences-to-announce-second-quarter-2020-financial-results-and-host-conference-call-and-webcast-on-august-6-2020 2022-02-28T11:37:09-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/62/achieve-life-sciences-announces-pricing-of-6-million-registered-direct-offering 2022-02-28T11:37:09-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/63/achieve-announces-successful-results-from-the-investigator-initiated-rauora-head-to-head-non-inferiority-clinical-trial-comparing-cytisinicline-and-chantix-varenicline-as-a-treatment-to-quit-smoking 2022-02-28T11:37:09-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/64/achieve-reports-financial-results-for-first-quarter-2020-and-provides-update-on-cytisinicline-development-program 2022-02-28T11:37:09-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/65/achieve-life-sciences-to-announce-first-quarter-2020-financial-results-and-host-conference-call-and-webcast-on-may-14-2020 2022-02-28T11:37:10-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/66/achieve-life-sciences-announces-private-placement-of-1-9-million 2022-02-28T11:37:10-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/67/achieve-reports-financial-results-for-fourth-quarter-and-year-end-2019-and-provides-update-on-cytisinicline-development-program 2022-02-28T11:37:11-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/68/achieve-life-sciences-announces-presentation-of-additional-cytisinicline-analyses-at-the-society-for-research-on-nicotine-tobacco-srnt-annual-meeting 2022-02-28T11:37:11-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/69/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2019-financial-results-and-host-conference-call-and-webcast-on-march-13-2020 2022-02-28T11:37:12-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/70/achieve-life-sciences-announces-agreement-with-the-freemind-group-to-assist-in-securing-non-dilutive-funding-to-evaluate-cytisinicline-in-vaping-and-e-cigarette-users 2022-02-28T11:37:12-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/71/achieve-life-sciences-university-of-bristol-and-oracle-corporation-announce-study-results-demonstrating-potential-for-accelerated-speed-of-drug-discovery 2022-02-28T11:37:12-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/72/achieve-life-sciences-inc-announces-closing-of-13-8-million-underwritten-public-offering-including-full-exercise-of-overallotment-option 2022-02-28T11:37:12-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/73/achieve-life-sciences-announces-pricing-of-12-million-underwritten-public-offering 2022-02-28T11:37:12-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/74/achieve-life-sciences-announces-completion-of-meeting-with-the-u-s-food-drug-administration-fda-on-cytisinicline-smoking-cessation-phase-3-clinical-development-program 2022-02-28T11:37:12-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/75/achieve-reports-financial-results-for-third-quarter-2019-and-provides-update-on-cytisinicline-development-program 2022-02-28T11:37:12-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/76/achieve-life-sciences-to-announce-third-quarter-2019-financial-results-and-host-conference-call-and-webcast-on-november-6-2019 2022-02-28T11:37:13-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/77/achieve-life-sciences-announces-presentation-of-cytisinicline-data-at-society-for-research-on-nicotine-tobacco-oceania-srnt-o-inaugural-conference 2022-02-28T11:37:13-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/78/achieve-life-sciences-announces-completion-of-maximum-tolerated-dose-study 2022-02-28T11:37:13-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/79/achieve-life-sciences-announces-final-phase-2b-orca-1-trial-data-presented-at-society-for-research-on-nicotine-tobacco-europe-srnt-e-19th-annual-conference 2022-02-28T11:37:13-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/80/achieve-life-sciences-to-host-investor-day-on-september-20th-including-roundtable-discussion-with-smoking-cessation-medical-experts-and-final-data-from-the-phase-2b-orca-1-trial 2022-02-28T11:37:13-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/81/achieve-life-sciences-announces-presentations-at-upcoming-investor-conferences 2022-02-28T11:37:14-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/82/c-o-r-r-e-c-t-i-o-n----achieve-life-sciences-inc 2022-02-28T11:37:14-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/83/achieve-reports-financial-results-for-second-quarter-2019-and-provides-cytisinicline-clinical-development-update 2022-02-28T11:37:14-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/84/achieve-life-sciences-to-announce-second-quarter-2019-financial-results-and-host-conference-call-and-webcast-on-august-8-2019 2022-02-28T11:37:15-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/85/achieve-life-sciences-extends-collaboration-with-the-national-institutes-of-health-to-advance-the-development-of-cytisinicline-for-smoking-cessation 2022-02-28T11:37:15-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/86/achieve-life-sciences-announces-phase-2b-orca-1-trial-data-accepted-for-oral-presentation-at-society-for-research-on-nicotine-tobacco-europe-srnt-e-19th-annual-conference 2022-02-28T11:37:15-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/87/achieve-life-sciences-announces-statistically-significant-improvement-in-quit-rates-for-simplified-cytisinicline-dosing-schedule-in-phase-2b-orca-1-dose-selection-trial 2022-02-28T11:37:15-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/88/achieve-receives-4-2-million-from-exercise-of-warrants 2022-02-28T11:37:15-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/89/achieve-announces-patent-granted-in-the-u-s-for-novel-formulation-of-cytisinicline 2022-02-28T11:37:15-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/90/achieve-reports-financial-results-for-first-quarter-2019-and-provides-cytisinicline-clinical-development-update 2022-02-28T11:37:15-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/91/achieve-life-sciences-to-announce-first-quarter-2019-financial-results-and-host-conference-call-and-webcast-on-may-15-2019 2022-02-28T11:37:15-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/92/achieve-life-sciences-announces-last-subject-last-visit-completed-in-phase-2b-orca-1-trial-of-cytisinicline-for-smoking-cessation 2022-02-28T11:37:16-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/93/achieve-life-sciences-to-present-at-hc-wainwright-global-life-sciences-conference-on-april-8-2019 2022-02-28T11:37:16-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/94/achieve-life-sciences-announces-successful-completion-of-the-second-and-final-dsmc-review-of-phase-2b-orca-1-trial-of-cytisinicline-for-smoking-cessation 2022-02-28T11:37:16-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/95/achieve-life-sciences-to-present-at-oppenheimers-29th-annual-healthcare-conference-on-march-20-2019 2022-02-28T11:37:16-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/96/achieve-reports-financial-results-for-year-end-2018-and-provides-cytisinicline-clinical-development-update 2022-02-28T11:37:16-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/97/achieve-life-sciences-to-announce-fourth-quarter-and-year-end-2018-financial-results-and-host-conference-call-and-webcast-on-march-14-2019 2022-02-28T11:37:16-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/98/achieve-announces-final-data-from-cytisinicline-phase-iii-multi-dose-pharmacokinetic-and-pharmacodynamics-pkpd-clinical-study-to-be-presented-at-society-for-research-on-nicotine-tobacco-annual-meeting 2022-02-28T11:37:16-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/99/achieve-life-sciences-announces-completion-of-enrollment-in-254-subject-phase-2b-trial-of-cytisinicline-for-smoking-cessation 2022-02-28T11:37:16-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/100/achieve-announces-update-on-cytisinicline-clinical-development-program 2022-02-28T11:37:16-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/101/achieve-reports-financial-results-for-third-quarter-2018-and-provides-cytisinicline-cytisine-clinical-development-update 2022-02-28T11:37:17-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/102/achieve-life-sciences-to-announce-third-quarter-2018-financial-results-and-host-conference-call-and-webcast-on-november-7-2018 2022-02-28T11:37:17-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/103/achieve-life-sciences-announces-initiation-of-phase-2b-orca-1-trial-evaluating-cytisinicline-cytisine-for-smoking-cessation 2022-02-28T11:37:17-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/104/achieve-announces-pricing-of-5-6-million-registered-direct-offering 2022-02-28T11:37:17-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/105/achieve-announces-results-of-clinical-study-demonstrating-similar-bioavailability-for-a-new-cytisine-formulation-in-fed-and-fasted-subjects 2022-02-28T11:37:18-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/106/achieve-to-present-at-the-ladenburg-thalmann-2018-healthcare-conference-on-october-2-2018 2022-02-28T11:37:18-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/107/achieve-announces-positive-cytisine-data-published-in-international-journal-of-drug-policy 2022-02-28T11:37:18-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/108/achieve-life-sciences-announces-cytisine-data-presented-at-the-society-for-research-on-nicotine-and-tobacco-europe-srnt-e-annual-conference 2022-02-28T11:37:18-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/109/achieve-to-present-at-the-h-c-wainwright-20th-annual-global-investment-conference-on-september-6-2018 2022-02-28T11:37:18-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/110/achieve-reports-financial-results-for-second-quarter-2018-and-provides-cytisine-clinical-development-update 2022-02-28T11:37:18-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/111/achieve-life-sciences-to-release-second-quarter-2018-financial-results-and-host-conference-call-and-webcast-on-august-8-2018 2022-02-28T11:37:19-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/112/achieve-life-sciences-announces-advancement-of-cytisine-development-program-following-meeting-with-the-fda 2022-02-28T11:37:19-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/113/achieve-announces-positive-cytisine-data-demonstrating-no-clinically-significant-drug-drug-interaction 2022-02-28T11:37:19-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/114/achieve-life-sciences-inc-announces-closing-of-a-13-8-million-underwritten-public-offering-and-full-exercise-of-over-allotment-option 2022-02-28T11:37:19-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/115/achieve-life-sciences-announces-pricing-of-12-million-underwritten-public-offering 2022-02-28T11:37:19-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/116/achieve-announces-publication-of-cytisine-data-for-next-generation-cytisine-molecules 2022-02-28T11:37:19-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/117/achieve-life-sciences-inc-announces-reverse-stock-split 2022-02-28T11:37:19-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/118/achieve-reports-financial-results-for-first-quarter-2018 2022-02-28T11:37:20-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/119/achieve-announces-patent-granted-on-novel-formulation-of-cytisine 2022-02-28T11:37:20-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/120/achieve-life-sciences-announces-cytisine-symposium-at-the-17th-world-conference-on-tobacco-or-health 2022-02-28T11:37:20-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/121/achieve-announces-recent-highlights-and-reports-year-end-2017-financial-results 2022-02-28T11:37:20-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/122/achieve-announces-preliminary-data-from-cytisine-phase-iii-multi-dose-pharmacokinetic-and-pharmacodynamics-pkpd-clinical-study 2022-02-28T11:37:20-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/123/achieve-announces-expansion-of-partnership-with-the-university-of-bristol-for-next-generation-cytisine-based-therapies-to-include-exclusive-rights-for-cytisine-development-across-multiple-therapeutic-categories 2022-02-28T11:37:20-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/124/achieve-announces-clinical-trial-supply-and-cooperation-agreement-with-the-university-of-auckland-for-the-evaluation-of-cytisine-compared-to-varenicline-for-smoking-cessation 2022-02-28T11:37:20-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/125/achieve-announces-results-of-clinical-study-demonstrating-similar-bioavailability-of-cytisine-in-fed-and-fasted-subjects 2022-02-28T11:37:20-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/126/achieve-reports-financial-results-for-third-quarter-2017 2022-02-28T11:37:21-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/127/achieve-to-present-at-the-29th-annual-piper-jaffray-healthcare-conference-on-november-28th-2017 2022-02-28T11:37:21-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/128/achieve-announces-availability-of-company-presentation-from-the-virtual-investor-conference 2022-02-28T11:37:21-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/129/achieve-announces-company-presentation-at-virtual-investor-conference-on-november-2-2017 2022-02-28T11:37:21-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/130/achieve-announces-exclusive-long-term-manufacturing-agreement-with-sopharma-for-clinical-and-commercial-supply-of-cytisine 2022-02-28T11:37:21-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/131/achieve-announces-advancement-of-cytisine-clinical-development-program 2022-02-28T11:37:21-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/132/achieve-announces-share-purchase-agreement-with-lincoln-park-capital-fund-llc 2022-02-28T11:37:22-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/133/achieve-announces-initiation-of-cytisine-clinical-development-program 2022-02-28T11:37:22-05:00 https://ir.achievelifesciences.com/news-events/press-releases/detail/134/achieve-announces-fda-acceptance-of-the-investigational-new-drug-application-ind-for-cytisine-as-a-smoking-cessation-treatment 2022-02-28T11:37:22-05:00 https://ir.achievelifesciences.com/news-events/ir-calendar/detail/20260324-fourth-quarter-2025-earnings-conference-call 2026-03-17T08:55:46-04:00 https://ir.achievelifesciences.com/news-events/ir-calendar/detail/20251106-third-quarter-2025-earnings-conference-call 2025-10-29T09:59:27-04:00 https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0001193125-26-121817/achv-20260324.htm 2026-03-24T16:13:20-04:00 https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0001193125-26-120690/achv-20251231.htm 2026-03-24T07:12:35-04:00 https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0001193125-26-120687/achv-20260324.htm 2026-03-24T07:05:50-04:00 https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0001193125-26-031806/ownership.html 2026-01-30T16:10:41-05:00 https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0001193125-26-031801/ownership.html 2026-01-30T16:10:00-05:00 https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0001193125-26-031795/ownership.html 2026-01-30T16:09:51-05:00 https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0001193125-26-031790/ownership.html 2026-01-30T16:07:38-05:00 https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0001193125-26-031782/ownership.html 2026-01-30T16:06:32-05:00 https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0001193125-26-031761/ownership.html 2026-01-30T16:05:35-05:00 https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/9999999995-26-000355/primary_doc.html 2026-01-30T06:09:03-05:00 https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0000038777-26-000017/primary_doc.html 2026-01-29T11:14:09-05:00 https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0001193125-26-021032/achv-20260123.htm 2026-01-23T16:05:41-05:00 https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0001193125-26-009831/ownership.html 2026-01-12T08:10:46-05:00 https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0001193125-25-311199/ownership.html 2025-12-08T16:01:38-05:00 https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0001172661-25-005187/primary_doc.html 2025-11-14T20:05:47-05:00 https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0001013594-25-001417/primary_doc.html 2025-11-14T10:55:19-05:00 https://ir.achievelifesciences.com/news-events/presentations/detail/9693/achieve-corporate-presentation-march-2026 2026-04-03T14:13:24-04:00 https://ir.achievelifesciences.com/disclaimer https://ir.achievelifesciences.com/sitemap